1 active not recruiting, 1 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow R-ICE: new trials by email Literature Review of R-ICE trials Research Report on R-ICE
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Trial of Epcoritamab Combinations in Subjects With B-cell Non-Hodgkin Lymphoma (B-NHL) rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, rituximab and lenalidomide, rituximab and bendamustine - Diffuse Large B-Cell Lymphoma, Follicular Lymphoma | Phase 1 / Phase 2 | Active not recruiting | Genmab | 543 | 2020-11-03 | 2026-10-06 |
| Oral Azacitidine Plus Salvage Chemotherapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma Oral azacitidine, R-ICE - Large B-Cell Diffuse Lymphoma | Phase 1 | Completed | Medical University of South Carolina | 9 | 2019-04-04 | 2024-10-28 |
Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Follicular (1)
Genmab (1) · Medical University of South Carolina (1)
United States (2) · Australia (1) · Belgium (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Italy (1) · Netherlands (1) · Norway (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Brian Hess, MD (1)
PMID 39792928, PMID 40920572, PMID 41784015, PMID 42622258, PMID 42660129
2023 (1)